{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "Proteomic studies have identified Ubiquilin-2 (UBQLN2), a protein involved in protein degradation, as a direct interactor of ATXN3.",
  "functions": [
    {
      "function": "Protein Homeostasis",
      "arrow": "binds",
      "cellular_process": "Co-immunoprecipitation studies in cultured cells failed to show an interaction between UBQLN2 and either normal or expanded ATXN3.",
      "effect_description": "While UBQLN2 is recruited to the protein aggregates in Huntington's disease (mutant HTT), it is not recruited to the aggregates in Spinocerebellar ataxia type 3 (mutant ATXN3). This suggests that ATXN3 is likely not a substrate for UBQLN2-mediated clearance.",
      "biological_consequence": [
        "Lack of interaction → Differential composition of protein aggregates in polyQ diseases → Distinct cellular responses to protein aggregation"
      ],
      "specific_effects": [
        "The absence of interaction distinguishes the pathology of SCA3 from that of Huntington's disease, where UBQLN2 is a key component of inclusions."
      ],
      "evidence": [
        {
          "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
          "year": 2015,
          "pmid": "26141599"
        }
      ],
      "_context": {
        "type": "direct",
        "query_protein": null,
        "chain": null
      },
      "interaction_effect": "binds",
      "direction": "main_to_primary",
      "interaction_direction": "main_to_primary",
      "pmids": [
        "26141599"
      ],
      "function_effect": "binding"
    }
  ],
  "arrow": "binds",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "binds"
    ]
  },
  "_validation_status": "rejected",
  "mechanism": "Co-immunoprecipitation studies in cultured cells failed to show an interaction between UBQLN2 and either normal or expanded ATXN3.",
  "effect": "While UBQLN2 is recruited to the protein aggregates in Huntington's disease (mutant HTT), it is not recruited to the aggregates in Spinocerebellar ataxia type 3 (mutant ATXN3). This suggests that ATXN3 is likely not a substrate for UBQLN2-mediated clearance.",
  "summary": "ATXN3 interacts with UBQLN2 to modulate protein homeostasis, ultimately affecting distinct cellular responses to protein aggregation.",
  "evidence": [
    {
      "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
      "year": 2015
    }
  ],
  "status": "INVALID",
  "interaction_effect": "binding",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 1
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 --binds--> UBQLN2:",
  "protein_a": "UBQLN2",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-24T12:52:47.823306Z",
  "last_updated": "2025-11-24T12:52:47.823306Z"
}